Literature DB >> 1622646

Lymphoma incidence in a Swedish county during 1969-1987.

U Martinsson1, B Glimelius, C Sundström.   

Abstract

The incidence of lymphoid malignancies (acute leukemias and myelomatosis excluded) during 1969-1987 in the County of Uppsala was calculated on the basis of the regional cancer register and local registers from the only oncological, hematological, dermatological and pathological departments in this well-defined geographical area. Of the 774 patients included, 639 had histopathological specimens available, all of which were re-examined. Seventy-nine patients were diagnosed on the basis of bone marrow investigations (greater than 70% re-examined, all had a low-grade non-Hodgkin's lymphoma = NHL) and 54 on fine-needle aspiration biopsies (not re-examined). Seventy-nine of the lymphoma diagnoses were based on autopsy specimens. The overall age standardized incidence was 16.2/100,000/year (NHL: 13.6, Hodgkin's disease = HD: 1.5) according to the Swedish 1970 census (according to world standard population: 10.2); male: 20.9 (12.9) and female: 12.4 (7.9). The annual change in trend was +3.0% +/- 2.6 (NHL: +3.6% +/- 2.4, HD: no change). The omission of the 54 'fine needle cases' led to an overall incidence of 15.0 (9.7) and an annual change in trend of +3.5% +/- 1.9. Among the histopathological specimens, an NHL was found in 524 patients and HD in 69. In 46 registered patients, the diagnosis malignant lymphoma was wrong. The diagnosis changed to NHL in 43 patients registered as HD.

Entities:  

Mesh:

Year:  1992        PMID: 1622646     DOI: 10.3109/02841869209108173

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  7 in total

1.  Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma.

Authors:  K E Smedby; M Akerman; H Hildebrand; B Glimelius; A Ekbom; J Askling
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

Review 2.  Epidemiology of Hodgkin's disease and non-Hodgkin's lymphoma.

Authors:  A J Swerdlow
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-05-07       Impact factor: 9.236

3.  Evidence of an association between non-Hodgkin's lymphoma and skin cancer.

Authors:  J Adami; M Frisch; J Yuen; B Glimelius; M Melbye
Journal:  BMJ       Date:  1995-06-10

4.  Occupational exposures, animal exposure and smoking as risk factors for hairy cell leukaemia evaluated in a case-control study.

Authors:  M Nordström; L Hardell; A Magnuson; H Hagberg; A Rask-Andersen
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

5.  Allergic conditions and risk of hematological malignancies in adults: a cohort study.

Authors:  Karin C Söderberg; Lars Hagmar; Judith Schwartzbaum; Maria Feychting
Journal:  BMC Public Health       Date:  2004-11-04       Impact factor: 3.295

6.  Global, regional, and national burden of Hodgkin lymphoma from 1990 to 2017: estimates from the 2017 Global Burden of Disease study.

Authors:  Linghui Zhou; Yujiao Deng; Na Li; Yi Zheng; Tian Tian; Zhen Zhai; Si Yang; Qian Hao; Ying Wu; Dingli Song; Dai Zhang; Jun Lyu; Zhijun Dai
Journal:  J Hematol Oncol       Date:  2019-10-22       Impact factor: 17.388

7.  Recent increase in the incidence of non-Hodgkin's lymphoma among young men and women in Denmark.

Authors:  H Hjalgrim; M Frisch; K Begtrup; M Melbye
Journal:  Br J Cancer       Date:  1996-04       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.